
Core Viewpoint - ANIXA BIOSCIENCES INC is identified as a promising momentum stock with a Momentum Style Score of A and a Zacks Rank of 2 (Buy), indicating potential for near-term price increases [3][12]. Momentum Style Score Analysis - The Momentum Style Score incorporates price changes and earnings estimate revisions, which are critical for assessing stock performance [2][9]. - ANIX's shares have increased by 7.39% over the past week, outperforming the Zacks Medical - Biomedical and Genetics industry, which rose by 5.43% during the same period [6]. - Over the past month, ANIX's price change is 27.82%, significantly higher than the industry's 6.65% [6]. Long-Term Performance Metrics - In the last quarter, ANIX shares rose by 12.21%, and over the past year, they increased by 27.34%, while the S&P 500 only moved 4.46% and 13.71%, respectively [7]. - The average 20-day trading volume for ANIX is 154,337 shares, indicating a bullish trend when combined with rising stock prices [8]. Earnings Outlook - In the past two months, one earnings estimate for ANIX has been revised upward, while none have been lowered, leading to an increase in the consensus estimate from -$0.41 to -$0.38 [10]. - For the next fiscal year, one estimate has also moved upwards with no downward revisions, suggesting positive sentiment around future earnings [10].